Product Information
DOXAZOSIN MESYLATE 1 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $0.0752 per EA under NDC 62135005190. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application on Oct 18, 2000.
Strength
1 mg/1
Manufacturer
Chartwell RX LLCNDC
62135005190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA075646FDA Approved
10/18/2000
On Market Since
10/18/2000
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 1 MG TAB has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 13.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0752 per EA |
|---|---|
| All-time high | $0.0856 (Feb 11, 2026) |
| All-time low | $0.0647 (Jan 22, 2025) |
| 52-week high | $0.0856 |
| 52-week low | $0.0752 |
| Median price | $0.0773 |
| Average price | $0.0760 |
| Largest weekly change | +13.2% (Sep 18, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxazosin mesylate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxazosin mesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 1 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 1 MG TAB, manufactured by Chartwell RX LLC, is $0.0752 per EA (NDC 62135005190), effective Sep 30, 2026.
How has the price of DOXAZOSIN MESYLATE 1 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has risen 13.9%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 1 MG TAB?
Since Jul 31, 2024, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has ranged from a low of $0.0647 (Jan 22, 2025) to a high of $0.0856 (Feb 11, 2026), with a median of $0.0773 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 1 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DOXAZOSIN MESYLATE 1 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXAZOSIN MESYLATE 1 MG TAB?
DOXAZOSIN MESYLATE 1 MG TAB (NDC 62135005190) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.